BG8 LewisY Control

C3d Control

CA-125, Control

CD3 Control

CD10 Control

CD11b Control

CD11c Control

CD13 Control

CD19 Control

CD23 Control

CD34 Control

CD35 Control

CD38 Control

CD41/ Integrin alpha IIb Control

CD71 Control

CD138 Control

CEA, Control

Cyclin B1 Control

Cyclin E1 Control

Claudin-1 Control

Clusterin/ Apolipoprotein J Control

c-Myc Control

c-Met/HGFR Control

Cytokeratin 5 & ERG Control

Cytokeratin 5 & 6 & ERG Control

Cytokeratin 7 & CDX2 Control

ERG Control

FOXA1 / HNF-3A Control

FOXP1 Control

FOXP3 Control

Hemoglobin A control

HLA-DR alpha chain, Control

IgG4 Control

IgG4 Control

INI-1 Control

Langerin Control

Cadherin17/LI-Cadherin Control

c-Myc Control

Melanoma Cocktail: HMB-45 Mart-1 & Tyrosinase Control

MDR-1 control

Mesothelin control

Anti-MUC2, control

Napsin A Control

The Silaris™ Influenza A&B Control Kit is intended for in vitro diagnostic use in qualitycontrol testing with the Silaris™ Influenza A&B Test.

The Silaris Dock is an electronic module which executes in vitro diagnostic tests on compatible Silaris Test Cassettes. It consists of anelectro-mechanical interface to a single Test Cassette. The Dock contains all electrical systems, controls and logic necessary toorchestrate in-vitro diagnostic tests within the inserted Test Cassette.

The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in vitro diagnostic test utilizing polymerasechain reaction (PCR) and lateral flow technology for the qualitative, visual detection and differentiation of influenza A andinfluenza B viral RNA. The Silaris Influenza A&B Test uses a nasal swab specimen collected from patients with signs andsymptoms of respiratory infection. Silaris Influenza A&B assay is intended as an aid in the diagnosis of influenza infectionsin conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenzaC virus.

The Silaris Starter Pack contains two (2) Silaris Influenza A&B kits and one (1) Silaris Dock for the purposes of starting up a clinical location.

The Silaris RSV Control Kit is intended for in vitro diagnostic use in quality control testing with the Silaris RSV Test

The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in vitro diagnostic test utilizing polymerasechain reaction (PCR) and lateral flow technology for the qualitative, visual detection and differentiation of influenza A andinfluenza B viral RNA. The Silaris Influenza A&B Test uses a nasal swab specimen collected from patients with signs andsymptoms of respiratory infection. Silaris Influenza A&B assay is intended as an aid in the diagnosis of influenza infectionsin conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenzaC virus.

The Silaris™ RSV Test performed on the Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chainreaction (PCR) and lateral flow technologies for the qualitative, visual detection of respiratory syncytial virus (RSV) viral RNA.The Silaris RSV Test uses a nasal swab specimen collected from patients with signs and symptoms of respiratory infection.The Silaris RSV Test is intended as an aid in the diagnosis of RSV infection in children and adults in conjunction with clinicaland epidemiological risk factors.